证券代码：605186 证券简称：健麾信息 公告编号：2025-030 上海健麾信息技术股份有限公司 关于归还临时补充流动资金的募集资金的公告 截至本公告披露日，公司实际使用闲置募集资金临时补充流动资金9,000.00 万元，已将上述募集资金全部归还至募集资金专用账户，并将募集资金的归还情 况告知了保荐机构及保荐代表人，不存在超期情形。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 本次归还募集资金金额（万元） | 9,000.00 | | --- | --- | | 尚未归还的募集资金金额（万元） | 0.00 | | 是否已归还完毕 | √是 □否 | | 归还完毕的具体时间 | 2025年10月20日 | 截至 2025 年 10 月 20 日，公司已累计归还临时补充流动资金的闲置 募集资金人民币_9,000.00_万元。 一、募集资金临时补充流动资金情况 上海健麾信息技术股份有限公司（以下简称"公司" ）于2024年10月29日 召开的第三届董事会第四次会议、第三届监事会第四次会议分别审议通过了《 ...

Market Overview - The medical consumables supply chain SPD sector increased by 0.41% compared to the previous trading day, with Jianfa Zhixin leading the gains [1] - The Shanghai Composite Index closed at 3863.89, up 0.63%, while the Shenzhen Component Index closed at 12813.21, up 0.98% [1] Stock Performance - Jianfa Zhixin (301584) closed at 29.30, up 4.46% with a trading volume of 186,400 shares and a transaction value of 534 million [1] - Dajia Weikang (301126) closed at 11.75, up 3.07% with a trading volume of 53,500 shares and a transaction value of 62.22 million [1] - Jianmo Information (605186) closed at 19.55, up 2.68% with a trading volume of 17,200 shares and a transaction value of 33.43 million [1] - Other notable performers include Hefei China (603122) up 1.91%, Langma Information (300288) up 1.48%, and Seli Medical (603716) up 1.48% [1] Capital Flow - The SPD sector experienced a net outflow of 43.97 million from institutional investors, while retail investors saw a net inflow of 16.33 million [2] - The sector's overall capital flow indicates a mixed sentiment, with institutional investors pulling back while retail investors are more active [2] Individual Stock Capital Flow - Seli Medical (603716) had a net inflow of 12.83 million from institutional investors, but a net outflow of 12.61 million from speculative funds [3] - Dajia Weikang (301126) saw a net inflow of 5.24 million from speculative funds, but a net outflow of 5.91 million from retail investors [3] - Huadong Pharmaceutical (000963) had a net inflow of 2.37 million from speculative funds, while retail investors experienced a net outflow of 4.64 million [3]

Group 1 - The core viewpoint indicates a decline in gold stocks, with Hunan Gold dropping over 4%, Laopu Gold falling over 3%, and Shandong Gold and Chifeng Gold decreasing over 2% [1] - Related ETFs for gold stocks have also seen a decline, with an overall drop of more than 2% [1] Group 2 - Specific ETF performance includes: - Gold Stock ETF (code: 159321) at 1.377, down 0.040 or -2.82% - Gold Stock ETF Fund (code: 159315) at 1.470, down 0.038 or -2.52% - Gold Stock ETF (code: 517520) at 1.797, down 0.046 or -2.50% - Gold Stock ETF (code: 159562) at 1.962, down 0.046 or -2.29% - Gold Stock ETF (code: 517400) at 1.421, down 0.033 or -2.27% - Gold Stock ETF Fund (code: 159322) at 1.461, down 0.033 or -2.21% [2] Group 3 - Analysts suggest that expectations of a Federal Reserve interest rate cut have opened up "valuation space" for gold prices, while geopolitical and economic policy uncertainties have increased gold's "safe-haven value" [2] - Active capital inflows are providing the "fuel" for price increases, with these three factors interwoven to form a solid foundation for the current gold bull market [2]

Core Points - The company, Shanghai Jianhui Information Technology Co., Ltd., will hold a half-year performance briefing on October 9, 2025, from 09:00 to 10:00 [2][4] - The briefing will be conducted in an interactive online format at the Shanghai Stock Exchange Roadshow Center [3][4] - Investors can submit questions for the briefing from September 24 to September 30, 2025, and the company will address common concerns during the session [2][5] Summary by Sections Meeting Details - The performance briefing is scheduled for October 9, 2025, from 09:00 to 10:00 [2][4] - The location for the meeting is the Shanghai Stock Exchange Roadshow Center, accessible online [2][4] - The meeting will allow for real-time interaction between the company and investors [3] Participation Information - Investors can participate by logging into the Shanghai Stock Exchange Roadshow Center on the scheduled date [4] - Questions can be pre-submitted via the Roadshow Center's website or through the company's email before the deadline [5] - Contact information for inquiries includes a designated contact person and email address [5]

Group 1 - The company, Jianhui Information (605186), announced that it will hold a 2025 semi-annual performance briefing on October 9, 2025 [1]

证券代码：605186 证券简称：健麾信息 公告编号：2025-029 上海健麾信息技术股份有限公司 关于召开 2025 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2025 年 10 月 09 日 （星期四） 09:00-10:00 会议召开地点：上海证券交易所上证路演中心（网址： 本次投资者说明会以网络互动形式召开，公司将针对 2025 年半 年度的经营成果及财务指标的具体情况与投资者进行互动交流和沟 通，在信息披露允许的范围内就投资者普遍关注的问题进行回答。 二、 说明会召开的时间、地点 （一）会议召开时间：2025年10月09日（星期四）09:00-10:00 （二） 会议召开地点：上证路演中心 （三） 会议召开方式：上证路演中心网络互动 https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2025 年 09 月 24 日 （星期三） 至 09 月 30 日 （星 期二）16:00 前登录上证路演中心网 ...

Core Viewpoint - The financial performance of Jianhui Information (605186) for the first half of 2025 shows a mixed picture, with revenue growth but a significant decline in net profit, raising concerns about the company's financial health and operational efficiency [1][2]. Financial Performance Summary - Total revenue for the first half of 2025 reached 159 million yuan, an increase of 9.03% year-on-year [1]. - Net profit attributable to shareholders was 5.03 million yuan, a decrease of 82.99% compared to the previous year [1]. - The gross profit margin fell to 44.72%, down 26.18% year-on-year, indicating reduced profitability [1]. - The net profit margin dropped to 1.28%, a decline of 93.44% year-on-year [1]. - Total expenses (selling, administrative, and financial) amounted to 40.75 million yuan, accounting for 25.68% of revenue, an increase of 5.86% year-on-year [1]. Cash Flow and Receivables - The company reported a significant increase in operating cash flow, with a net cash flow from operating activities improving by 80.58% year-on-year [6]. - Accounts receivable represented 1478.08% of net profit, indicating a high level of outstanding payments [1][6]. Cost Structure and Expenses - Operating costs increased by 52.89%, attributed to higher sales and a greater proportion of new products [2]. - Management expenses rose by 14.46%, primarily due to increased depreciation from the conversion of logistics projects into fixed assets [4]. - Financial expenses surged by 100.93%, driven by an increase in short-term borrowings [6]. Business Model and Market Position - The company is focusing on expanding into new business areas such as intelligent logistics and mobile robotics, which have shown some success [2]. - Historical data indicates a median Return on Invested Capital (ROIC) of 16.34%, but the recent performance shows a decline, with a ROIC of only 2.8% last year [6]. - The company’s reliance on research and marketing for performance necessitates a thorough examination of these drivers [6].

Overview - The company announced a provision for asset impairment for the first half of 2025, amounting to a total credit impairment loss of 16,045,044.10 yuan [2][4]. Provision for Asset Impairment - The provision is made in accordance with the "Enterprise Accounting Standards" and the company's accounting policies to reflect the financial status and operating results accurately [2]. - The company assesses the credit risk of financial instruments by comparing the risk of default at the balance sheet date with that at initial recognition, determining if there has been a significant increase in credit risk [3]. Financial Impact - The provision for impairment will reduce the company's total profit by 16.045 million yuan for the current period [4]. - This provision is consistent with the "Enterprise Accounting Standards" and is based on the company's actual situation, ensuring a true and accurate reflection of the asset status without affecting the company's operations significantly [4]. Additional Notes - The financial data related to the impairment provision has not been audited by an accounting firm and will be confirmed by the annual audit [4].

证券代码：605186 证券简称： 健麾信息 公告编号：2025-028 根据《企业会计准则》以及上海健麾信息技术股份有限公司（以下简称"公 司"）会计政策的相关规定，为真实、客观地反映公司的财务状况和经营成果， 基于谨慎性原则，公司对截至 2025 年 6 月 30 日存在减值迹象的相关资产计提减 值准备。2025 年半年度确认的信用减值损失总额为 16,045,044.10 元。主要如下： 单位：元 | 序号 | 项目 | 本期发生额 | | --- | --- | --- | | 一 | 信用减值损失 | 16,045,044.10 | | 其中： | 应收账款坏账损失 | 16,045,044.10 | | 合计 | | 16,045,044.10 | 二、计提依据 本公司对以摊余成本计量的金融资产、以公允价值计量且其变动计入其他综 合收益的金融资产（债务工具）和财务担保合同等以预期信用损失为基础进行减 值会计处理。 上海健麾信息技术股份有限公司 关于 2025 年半年度计提资产减值准备的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性 ...

Core Viewpoint - The report highlights a significant decline in profitability for Shanghai Jianhui Information Technology Co., Ltd. in the first half of 2025, despite a 9.03% increase in revenue compared to the same period last year. The company is focusing on expanding its smart pharmacy and logistics automation business to counteract the challenges posed by a slowing economy and changing market conditions [2][3][10]. Company Overview and Financial Indicators - Company Name: Shanghai Jianhui Information Technology Co., Ltd. [2] - Revenue for the first half of 2025 reached approximately 158.67 million RMB, up from 145.52 million RMB in the same period last year [2][3]. - Total profit decreased by 93.90% to approximately 2.11 million RMB, while net profit attributable to shareholders fell by 82.99% to about 5.03 million RMB [2][3]. - The company's net assets increased slightly by 0.47% to approximately 1.08 billion RMB, while total assets decreased by 1.46% to about 1.44 billion RMB [2][3]. Business Performance Analysis - The increase in revenue is attributed to the company's efforts in expanding its smart pharmacy and logistics automation sectors, which have shown some success despite the overall challenging market environment [3][10]. - Operating costs surged by 52.89% due to the increase in revenue and a higher proportion of new products, leading to a decrease in gross profit margins [3][10]. - Sales expenses rose by 12.02%, and management expenses increased by 14.46%, primarily due to the depreciation of fixed assets related to the medical logistics project [3][10]. - Financial expenses doubled, primarily due to increased short-term borrowing costs [3][10]. Industry Context - The company operates within the specialized equipment manufacturing industry, specifically in the sector of automated pharmacy management systems [4][5]. - The demand for automated pharmacy solutions is growing, driven by the need for efficiency and cost reduction in healthcare settings, particularly in response to increasing medication management complexities [5][6][7]. - The Chinese healthcare system is undergoing reforms that are expected to enhance the market environment for automated pharmacy solutions, as hospitals seek to improve service quality and operational efficiency [8][9]. Strategic Initiatives - The company is actively pursuing international expansion, having established partnerships in markets such as Saudi Arabia, Taiwan, and several European countries to enhance its global footprint [15][16]. - Collaborations with major players in the pharmaceutical retail sector aim to innovate and implement smart retail solutions, leveraging both online and offline platforms [17][18]. - Continuous investment in research and development is a priority, with ongoing projects focused on enhancing product offerings and adapting to market needs [18][19].